Sprouts Farmers Market (SFM) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jul, 2026Executive summary
Net sales for Q3 2024 increased 14% year-over-year to $1.95 billion, driven by new store openings and 8.4% comparable store sales growth, with robust in-store and e-commerce traffic and a focus on health-oriented, differentiated products.
Net income rose 40% to $91.6 million, with diluted EPS up 42% to $0.91, reflecting higher gross profit, margin expansion, and share repurchases.
The company operated 428 stores in 23 states as of September 29, 2024, with plans to open 33 new stores in 2024, focusing on smaller, high-return formats and supply chain optimization.
Continued investments in infrastructure, technology, and talent support long-term growth, with strategic initiatives in omnichannel engagement and sustainability.
Targeting higher-income, health-conscious consumers, with an average household income of $121K and 49% earning over $100K.
Financial highlights
Q3 2024 net sales: $1.95 billion (+14% year-over-year); comparable store sales growth: 8.4%.
Gross margin: 38.1% (up from 36.5% in Q3 2023), attributed to improved shrink and inventory management.
Q3 2024 net income: $91.6 million (+40% year-over-year); diluted EPS: $0.91 (+42%).
Operating cash flow for the first nine months: $520 million; capital expenditures: $132 million net of landlord reimbursement.
Cash and equivalents at quarter-end: $310 million; no long-term debt outstanding.
Outlook and guidance
FY 2024 net sales growth projected at 12%, with comparable store sales growth at 7%.
Adjusted EBIT guidance: $490–$495 million; adjusted EPS: $3.64–$3.68.
Q4 2024 comp sales expected at 8–10%, adjusted EPS $0.67–$0.71.
33 new stores planned for 2024; two Florida openings postponed to Q1 2025 due to hurricane impacts.
Long-term targets include ~10% annual unit growth, stable EBIT margins, and low double-digit earnings growth.
Latest events from Sprouts Farmers Market
- 14% sales growth and record EPS in 2025, with 2026 guidance signaling slower gains.SFM
Q4 20258 Jul 2026 - Q2 net sales up 12%, EPS up 45%, and gross margin at 37.9% with robust store growth.SFM
Q2 20248 Jul 2026 - Q2 2025 delivered 17% sales growth, 44% EPS gain, and robust store and margin expansion.SFM
Q2 20258 Jul 2026 - 2024 saw 13% sales growth, 32% EPS gain, and margin expansion; 2025 targets double-digit growth.SFM
Q4 20248 Jul 2026 - Directors elected, all proposals adopted, and auditor ratified with no Q&A from shareholders.SFM
AGM 202620 May 2026 - Loyalty, innovation, and store growth drive strong performance and future confidence.SFM
21st Annual Global Farm to Market Conference19 May 2026 - Q1 2026 sales up 4% to $2.33B, EPS down, with strong expansion and robust share repurchases.SFM
Q1 20268 May 2026 - Strong growth, financials, and a differentiated health-focused experience drive long-term value.SFM
Investor presentation29 Apr 2026 - Virtual annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.SFM
Proxy filing7 Apr 2026